These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34780264)

  • 41. The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China.
    Zeng L; Zhang J; Li C; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Zhang X
    Infect Genet Evol; 2020 Aug; 82():104319. PubMed ID: 32278145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea.
    Lee MY; Choi HJ; Choi JY; Song M; Song Y; Kim SW; Chang HH; Jung SI; Kim YS; Ki HK; Son JS; Kwon KT; Heo ST; Yeom JS; Shin SY; Chung DR; Peck KR; Song JH; Ko KS
    J Infect; 2010 Feb; 60(2):146-53. PubMed ID: 19932131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequency of DNA gyrase and topoisomerase IV mutations and plasmid-mediated quinolone resistance genes among Escherichia coli and Klebsiella pneumoniae isolated from urinary tract infections in Azerbaijan, Iran.
    Azargun R; Soroush Barhaghi MH; Samadi Kafil H; Ahangar Oskouee M; Sadeghi V; Memar MY; Ghotaslou R
    J Glob Antimicrob Resist; 2019 Jun; 17():39-43. PubMed ID: 30445211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant.
    Demirci-Duarte S; Unalan-Altintop T; Eser OK; Cakar A; Altun B; Sancak B; Gur D
    Diagn Microbiol Infect Dis; 2020 Sep; 98(1):115098. PubMed ID: 32603974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. qnr, aac(6')-Ib-cr and qepA genes in Escherichia coli and Klebsiella spp.: genetic environments and plasmid and chromosomal location.
    Ruiz E; Sáenz Y; Zarazaga M; Rocha-Gracia R; Martínez-Martínez L; Arlet G; Torres C
    J Antimicrob Chemother; 2012 Apr; 67(4):886-97. PubMed ID: 22223228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential Afa/Dr Fimbriae Expression in the Multidrug-Resistant Escherichia coli ST131 Clone.
    Alvarez-Fraga L; Phan MD; Goh KGK; Nhu NTK; Hancock SJ; Allsopp LP; Peters KM; Forde BM; Roberts LW; Sullivan MJ; Totsika M; Beatson SA; Ulett GC; Schembri MA
    mBio; 2022 Feb; 13(1):e0351921. PubMed ID: 35038925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Escherichia coli ST1193: Following in the Footsteps of E. coli ST131.
    Pitout JDD; Peirano G; Chen L; DeVinney R; Matsumura Y
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0051122. PubMed ID: 35658504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluoroquinolone Resistance Mechanisms by Molecular Epidemiologic Study of Ciprofloxacin-Nonsusceptible
    Yang HS; Kim Y; Cho SY; Nam YS; Oh TS; Park KS; Kim HC; Lee HJ
    Ann Clin Lab Sci; 2017 Aug; 47(4):511-515. PubMed ID: 28801381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution of ciprofloxacin-resistance genes among ST131 and non-ST131 clones of
    Rasoulinasab M; Shahcheraghi F; Feizabadi MM; Nikmanesh B; Hajihasani A; Aslani MM
    Iran J Microbiol; 2021 Jun; 13(3):294-302. PubMed ID: 34540167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations.
    Vingopoulou EI; Siarkou VI; Batzias G; Kaltsogianni F; Sianou E; Tzavaras I; Koutinas A; Saridomichelakis MN; Sofianou D; Tzelepi E; Miriagou V
    J Antimicrob Chemother; 2014 Aug; 69(8):2076-80. PubMed ID: 24722836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibiotic resistance begets more resistance: chromosomal resistance mutations mitigate fitness costs conferred by multi-resistant clinical plasmids.
    Nair RR; Andersson DI; Warsi OM
    Microbiol Spectr; 2024 May; 12(5):e0420623. PubMed ID: 38534122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
    Yamane K; Wachino J; Suzuki S; Kimura K; Shibata N; Kato H; Shibayama K; Konda T; Arakawa Y
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3354-60. PubMed ID: 17548499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-
    Kanamori H; Parobek CM; Juliano JJ; Johnson JR; Johnston BD; Johnson TJ; Weber DJ; Rutala WA; Anderson DJ
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584139
    [No Abstract]   [Full Text] [Related]  

  • 54. The Challenge of Global Emergence of Novel Colistin-Resistant
    Taati Moghadam M; Mirzaei M; Fazel Tehrani Moghaddam M; Babakhani S; Yeganeh O; Asgharzadeh S; Farahani HE; Shahbazi S
    Microb Drug Resist; 2021 Nov; 27(11):1513-1524. PubMed ID: 33913748
    [No Abstract]   [Full Text] [Related]  

  • 55. In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates.
    Liu X; Lazzaroni C; Aly SA; Thungrat K; Boothe DM
    Vet Microbiol; 2014 Dec; 174(3-4):514-522. PubMed ID: 25465666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Draft genome sequence of an Escherichia coli ST410 isolate co-harbouring bla
    Rzeczkowska M; Wołkowicz T; Zacharczuk K; Gierczyński R; Semczuk K; Dzierżanowska-Fangrat K; Piekarska K
    J Glob Antimicrob Resist; 2019 Mar; 16():120-122. PubMed ID: 30553112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
    Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of ceftolozane-tazobactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
    Johnston BD; Thuras P; Johnson JR
    PLoS One; 2018; 13(7):e0200442. PubMed ID: 29990385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.
    Colpan A; Johnston B; Porter S; Clabots C; Anway R; Thao L; Kuskowski MA; Tchesnokova V; Sokurenko EV; Johnson JR;
    Clin Infect Dis; 2013 Nov; 57(9):1256-65. PubMed ID: 23926176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluoroquinolone-Resistant Sequence Type 131 Subgroups O25b and O16 Among Extraintestinal Escherichia coli Isolates from Community-Acquired Urinary Tract Infections.
    Hefzy EM; Hassuna NA
    Microb Drug Resist; 2017 Mar; 23(2):224-229. PubMed ID: 27214282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.